Karen Tkach Tuzman - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Karen Tkach Tuzman's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Karen Tkach Tuzman
Verified
Director of Biopharma Intelligence, BioCentury
San Francisco
Beats
Depression and Mental Health
Drugs, sport, climate, science, health, education, business, games, dating and relationships, home and family
Content
By Karen Tkach Tuzman Verified| BioCentury Verified ARTICLE | Politics, Policy & LawFour main types: topic-based grant cancellation, overhead funding reduction, clawbacks from individual universities, and cuts to NIH By Karen Tkach Tuzman, Director of Biopharma IntelligenceThe Trump administration has broken with decades of bipartisan support for biomedical research, launching a coordinated effort to shrink NIH’s grantmaking portfolio, curtail intramural research and reorient priorities.
By Karen Tkach Tuzman Verified| BioCentury Verified ARTICLE | Emerging Company Profile The Massachusetts-based company launched a microRNA-based liquid biopsy test for endometriosis, with an eye toward disease monitoring and drug development By Karen Tkach Tuzman, Director of Biophrama Intelligence Heranova thinks the similarities between endometriosis and cancer will make the notoriously difficult-to-diagnose disease amenable to non-invasive detection via liquid biopsy of nucleic acids from uterine lining cells undergoing excessive growth,...
By Karen Tkach Tuzman Verified| BioCentury Verified ARTICLE | Politics, Policy & LawFour main types: topic-based grant cancellation, overhead funding reduction, clawbacks from individual universities, and cuts to NIH By Karen Tkach Tuzman, Director of Biopharma IntelligenceThe Trump administration has broken with decades of bipartisan support for biomedical research, launching a coordinated effort to shrink NIH’s grantmaking portfolio, curtail intramural research and reorient priorities.
Company Info
BioCentury
BioCentury Inc. is a biotechnology-focused business intelligence and analytics company based in Redwood City, California. With over 30 years of experience, it specializes in providing strategic insights and data analysis tailored to the biopharma and biotech industries. The company reported a revenue of $16.2 million. BioCentury offers the BCIQ platform, which includes modules for tracking companies, products, and financial data. This platform helps clients identify trends, partnerships, and investment opportunities. Additionally, BioCentury provides analytical content that includes market trend analysis, visual data tools, and expert interviews. The company also facilitates networking through exclusive events and workshops, connecting C-suite executives and investors within the biopharma community.
Chicago, United States
+1 650-595-5333
Founded: 1992